Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cyril J. Empig
Observed names:
C EMPIG,
C Empig,
C. Empig,
Cyril Empig,
Cyril L. Empig
Institution:
NeoGenomics (United States)
Observed institutions:
University of Southern California,
Gladstone Institutes,
University of California, Los Angeles,
University of California, San Francisco,
Cassava Sciences (United States),
Avid Bioservices (United States),
USC Norris Comprehensive Cancer Center,
NeoGenomics (United States)
show all 8
OpenAlex ID:
A5027733137
Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer
2016
·
R B Birge
, S Boeltz
, et al.
·
Cell Death and Differentiation
·
783
PDF
Folate Receptor-α Is a Cofactor for Cellular Entry by Marburg and Ebola Viruses
2001
·
Stephen Y. Chan
, Cyril J. Empig
, et al.
·
Cell
·
222
PDF
LC16m8: An attenuated smallpox vaccine
2006
·
Julie Kenner
, Fiona Cameron
, et al.
·
Vaccine
·
192
PDF
Association of the Caveola Vesicular System with Cellular Entry by Filoviruses
2002
·
Cyril J. Empig
, Mark A. Goldsmith
·
Journal of Virology
·
157
Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression
2017
·
Canan Kasikara
, Sushil Kumar
, et al.
·
Molecular Cancer Research
·
144
Identification of a Lipopolysaccharide Binding Domain in CD14 between Amino Acids 57 and 64
1995
·
Todd S.-C. Juan
, Eric Hailman
, et al.
·
Journal of Biological Chemistry
·
128
PDF
Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults
2011
·
J. S. Kennedy
, M. Gurwith
, et al.
·
The Journal of Infectious Diseases
·
106
PDF
Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge
2005
·
C EMPIG
, J KENNER
, et al.
·
Vaccine
·
61
Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity
2014
·
Stuart D Dowall
, David A Matthews
, et al.
·
Genome biology
·
52
PDF
Pre-Clinical Evaluation of a 213Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication
2012
·
Ekaterina Dadachova
, Scott G. Kitchen
, et al.
·
PLoS ONE
·
40
PDF
Receptor-Specific Targeting Mediated by the Coexpression of a Targeted Murine Leukemia Virus Envelope Protein and a Binding-Defective Influenza Hemagglutinin Protein
2001
·
Amy H. Lin
, Nori Kasahara
, et al.
·
Human Gene Therapy
·
39
Effective Binding of a Phosphatidylserine-Targeting Antibody to Ebola Virus Infected Cells and Purified Virions
2015
·
S. D. Dowall
, V. A. Graham
, et al.
·
Journal of Immunology Research
·
19
PDF
Catheterized guinea pigs infected with Ebola Zaire virus allows safer sequential sampling to determine the pharmacokinetic profile of a phosphatidylserine-targeting monoclonal antibody
2012
·
Stuart Dowall
, Irene Taylor
, et al.
·
Antiviral Research
·
17
Quantitation of MoMuLV Envelope Protein on the Cell Surface
1998
·
Hong Yu
, Cyril Empig
, et al.
·
Virology
·
14
Complementation of a Binding-Defective Retrovirus by a Host Cell Receptor Mutant
2004
·
Zhaohui Qian
, Hongzhe Wang
, et al.
·
Journal of Virology
·
10
Correction: Pre-Clinical Evaluation of a213Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication
2012
·
Ekaterina Dadachova
, Scott G. Kitchen
, et al.
·
PLoS ONE
·
8
PDF
Abstract S05-02: Plant viral nanoparticle-based adjuvants for cancer immunotherapy and COVID-19 vaccines
2021
·
Nicole F. Steinmetz
, Jonathan K. Pokorski
, et al.
·
Clinical Cancer Research
·
1
Abstract B119: Characterization of a phosphatidylserine, TAM receptor (Tyro3, Axl, Mertk), PDL1 axis in breast cancer
2016
·
Canan Kasikara
, Sushil Kumar
, et al.
·
Cancer Immunology Research
Show more works
View as search
Works count:
18
Citation count:
1,993
H-index:
14
I10-index:
15
Year
Topic
Type